Dehydroepiandrosterone suppresses interleukin 10 synthesis in women with systemic lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 63, Issue 12, 2004, Pages 1623-1626

  Chang, D M ^a   Chu, S J ^a   Chen, H C ^a   Kuo, S Y ^a   Lai, J H ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; ESTRADIOL; GAMMA INTERFERON; HYDROXYCHLOROQUINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; METHOTREXATE; PLACEBO; PRASTERONE; PREDNISONE;

ADULT; ARTICLE; CHINESE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE DETERMINATION; HUMAN; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANTIRHEUMATIC AGENTS; DEHYDROEPIANDROSTERONE; DOUBLE-BLIND METHOD; ESTRADIOL; FEMALE; HUMANS; INTERLEUKIN-10; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; TESTOSTERONE;

EID: 9644269013     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2003.016576     Document Type: Article

References (37)

1. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus. Guidelines for referral and management of systemic lupus erythematosus in adults. Arthritis Rheum 1999;42:1785-96.
2. Lahita RG, Bradlow HL, Ginzler E, Pang S, New M. Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 1987;30:241-8.
3. Jungers P, Nahoul K, Pelissier C, Dougados M, Tron F, Bach JF. Low plasma androgens in women with active or quiescent systemic lupus erythematosus. Arthritis Rheum 1982;25:454-7.
4. Parker LN. Control of adrenal androgen secretion. Endocrinol Metab Clin North Am 1991;20:401-21.
5. Ebeling P, Koivisto VA. Physiological importance of dehydroepiandrosterone. Lancet 1994;343:1479-81.
6. Labrie F, Belanger A, Simard J, Van Luu-The, Labrie C. DHEA and peripheral androgen and estrogen formation: Intracinology. Ann N Y Acad Sci 1995;774:16-28.
7. Schmidt M, Kreutz M, Loffler G, Scholmerich J, Straub RH. Conversion of dehydroepiandrosterone to downstream steroid hormones in macrophages. J Endocrinology 2000;164:161-9.
8. van Vollenhoven RF, Engleman EG, McGuire JL. An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum 1994;37:1305-10.
9. van Vollenhoven RF, Engleman EG, McGuire JL. Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, plocebo-controlled, randomized clinical trial. Arthritis Rheum 1995;38:1826-31.
10. Petri MA, Lahita RG, Van Vollenhoven RF, Merrill JT, Schiff M, Ginzler EM, et al. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2002;46:1820-9.
11. Mease PJ, Merrill JT, Lahita RG, Petri MA, Ginzler EM, Katz RS, et al. GL701 (prasterone, dehydrooepiandrosterone) improves systemic lupus erythematosus. Arthritis Rheum 2000;43(Suppl 1):S271.
12. M Petri, R Ramsey-Goldman, S Manzi, P Mease, E Ginzler, M Schiff, K Schwartz. Lupus disease activity and bone mineral density in women with active lupus: results of a double-blind, multicenter trial comparing prasterone with placebo. Rheumatology 2003;42(Suppl 1):19.
13. Chang DM, Lan JL, Lin HY, Luo SF. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus. Arthritis Rheum 2002;46:2924-27.
14. Handwerger BS, Rus V, da Silva L, Via CS. The role of cytokines in the immunopathogenesis of lupus. Springer Semin Immunopathol 1994;16:153-80.
15. Al-Janadi M, Al-Balla S, AL-Dalaan A, Raziuddin S. Cytokines profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic disease. J Clin Immunol 1993;13:58-67.
16. Takemura T, Yoshioka K, Murakami K, Akano N, Okada M, Aya N, et al. Cellular localization of inflammatory cytokines in human glomerulonephritis. Virchows Archiv 1994;424:459-64.
17. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
18. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-18.
19. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI: A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
20. Lahita RG. Gender and age in lupus. In:Systemic lupus erythematosus, 3rd edn. San Diego: Academic Press, 1999:129.
21. Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus pregnancy center experience. Arthritis Rheum 1991;34:1538-45.
22. Lucas JA, Ahmed SA, Casey ML, MacDonald PC. Prevention of autoantibody formation and prolonged survival in New Zealand black/New Zealand white F1 mice fed dehydroisoandrosterone. J Clin invest 1985;75:2091-93.
23. Mastunaga A, Miller BC, Cottam GL. Dehydroisoandrosterone prevention of autoimmune disease in NZB/W F1 mice: Lack of an effect on associated immunological abnormalities. Biochem Biophys Acta 1989;992:265.
24. Daynes RA, Dudley DJ, Araneo BA. Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. Eur J Immunol 1990;20:793-802.
25. Suzuki T, Suzuki N Daynes RA, Engleman EG. Dehydroepiandrosterone enhances IL2 production and cytoxic effector function of human T cells. Clin Immunol Immunopathol 1991;61:202-11.
26. Inserra P, Zhang Z, Ardestani SK, Araghi-Niknam M, Liang B, Jiang S, Shaw D, Molitor M, Elliott K, Watson RR. Modulation of cytokine production by dehydroepiandrosterone plus melatonin supplementation of old mice. Proc Soc Exp Biol Med 1998;218:76-82.
27. Araghi-Niknam M, Zhang Z, Jiang S, Call O, Eskelson CD, Watson RR. Cytokine dysregulation and increased oxidation is prevented by dehydroepiandrosterone in mice infected with murine leukemia retrovirus. Proc Soc Exp Biol Med 1997;216:386-91.
28. Tabata N, Tagami H, Terui T. Dehydroepiandrosterone may be one of the regulators of cytokine production in atopic dermatitis. Arch Dermatol Res 1997;287:410-14.
29. Fitch FW, Lancki DW, Gajewski TF. T-cell mediated immune regulation. In: Paul WE, eds. Fundamental immunology. New York: Raven, 1993:801-35.
30. Durum SK, Oppenheim JJ. Proinflammatory cytokines and immunity. In: Paul WE, eds. Fundamental immunology. New York: Raven, 1993:801-35.
31. Houssiau FA, Lefebvre C, Vanden Berghe M, Lambert M, Devogelaer JP, Renauld JC. Serum interleukin-10 titers in systemic lupus erythematosus reflect disease activity, Lupus 1995;4:393-5.
32. Lorente L, Richaud-Patin Y, Fior R, Alcocer-Varela J, Wijdenes J, Fourrier BM, et al. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren syndrome, and systemic lupus erythematosus. Arthritis Rheum 1994;37:1647-55.
33. Richaud-Patin Y, Alcocer-Varela J, Llorente L. High levels of TH2 cytokine gene expression in systemic lupus erythematosus. Rev Invest Clin 1995;47:267-72.
34. Hagiwara E, Gourley MF, Lee S, Klinman DM. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio on interkeukin-10: interferon-γ-secreting cells in the peripheral blood. Arthritis, Rheum 1996;39:379-85.
35. Daynes RA, Dudley DJ, Araneo BA. Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin-2 synthesis by helper T cells. Eur J Immunol 1990;20:793-9.
36. Suzuki T, Suzuki N, Engleman EG. Low serum levels of dehydroepiandrosterone may cause deficient IL-2 production by lymphocytes from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1995;99:251-7.
37. Daynes RA, Araneo BA, Dowell TA. Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J Exp Med 1990;171:979-83.